塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/11/07 | 1,008 | 1,014 | 996 | 1,012 | -6 | -0.6% | 1,849,700 |
2011/11/04 | 1,019 | 1,021 | 1,011 | 1,018 | +9 | +0.9% | 1,644,600 |
2011/11/02 | 1,015 | 1,027 | 1,009 | 1,009 | -6 | -0.6% | 2,162,900 |
2011/11/01 | 1,054 | 1,055 | 1,007 | 1,015 | -60 | -5.6% | 3,555,300 |
2011/10/31 | 1,060 | 1,101 | 1,055 | 1,075 | +15 | +1.4% | 3,159,600 |
2011/10/28 | 1,058 | 1,064 | 1,049 | 1,060 | +17 | +1.6% | 3,292,600 |
2011/10/27 | 1,059 | 1,063 | 1,036 | 1,043 | -11 | -1% | 3,047,600 |
2011/10/26 | 1,057 | 1,061 | 1,048 | 1,054 | -15 | -1.4% | 2,038,000 |
2011/10/25 | 1,082 | 1,085 | 1,067 | 1,069 | -15 | -1.4% | 1,287,400 |
2011/10/24 | 1,086 | 1,092 | 1,082 | 1,084 | -1 | -0.1% | 1,269,400 |
2011/10/21 | 1,103 | 1,106 | 1,081 | 1,085 | -25 | -2.3% | 1,247,800 |
2011/10/20 | 1,116 | 1,119 | 1,103 | 1,110 | -5 | -0.4% | 1,244,100 |
2011/10/19 | 1,106 | 1,120 | 1,105 | 1,115 | +10 | +0.9% | 1,527,700 |
2011/10/18 | 1,105 | 1,111 | 1,098 | 1,105 | -5 | -0.5% | 859,400 |
2011/10/17 | 1,115 | 1,118 | 1,096 | 1,110 | +10 | +0.9% | 1,371,600 |
2011/10/14 | 1,120 | 1,120 | 1,100 | 1,100 | -20 | -1.8% | 2,201,000 |
2011/10/13 | 1,126 | 1,130 | 1,113 | 1,120 | -5 | -0.4% | 1,537,400 |
2011/10/12 | 1,133 | 1,139 | 1,120 | 1,125 | -7 | -0.6% | 1,409,600 |
2011/10/11 | 1,142 | 1,149 | 1,128 | 1,132 | +8 | +0.7% | 1,544,200 |
2011/10/07 | 1,135 | 1,140 | 1,120 | 1,124 | -1 | -0.1% | 1,677,000 |
2011/10/06 | 1,134 | 1,142 | 1,123 | 1,125 | -2 | -0.2% | 2,269,900 |
2011/10/05 | 1,137 | 1,145 | 1,121 | 1,127 | -7 | -0.6% | 1,958,500 |
2011/10/04 | 1,130 | 1,138 | 1,125 | 1,134 | +3 | +0.3% | 1,952,200 |
2011/10/03 | 1,138 | 1,141 | 1,125 | 1,131 | -22 | -1.9% | 2,043,800 |
2011/09/30 | 1,149 | 1,158 | 1,148 | 1,153 | +4 | +0.3% | 2,410,100 |
2011/09/29 | 1,143 | 1,151 | 1,137 | 1,149 | -1 | -0.1% | 1,594,400 |
2011/09/28 | 1,144 | 1,158 | 1,141 | 1,150 | -6 | -0.5% | 1,330,600 |
2011/09/27 | 1,157 | 1,162 | 1,147 | 1,156 | +10 | +0.9% | 1,710,200 |
2011/09/26 | 1,162 | 1,179 | 1,141 | 1,146 | -7 | -0.6% | 1,568,600 |
2011/09/22 | 1,156 | 1,158 | 1,145 | 1,153 | -15 | -1.3% | 1,812,400 |
2011/09/21 | 1,173 | 1,180 | 1,166 | 1,168 | +1 | +0.1% | 607,300 |
2011/09/20 | 1,170 | 1,178 | 1,163 | 1,167 | -7 | -0.6% | 826,600 |
2011/09/16 | 1,178 | 1,185 | 1,168 | 1,174 | +15 | +1.3% | 1,373,700 |
2011/09/15 | 1,158 | 1,163 | 1,152 | 1,159 | +19 | +1.7% | 1,747,400 |
2011/09/14 | 1,147 | 1,159 | 1,140 | 1,140 | -12 | -1% | 1,327,100 |
2011/09/13 | 1,150 | 1,163 | 1,146 | 1,152 | +7 | +0.6% | 1,710,900 |
2011/09/12 | 1,151 | 1,156 | 1,143 | 1,145 | -30 | -2.6% | 1,449,600 |
2011/09/09 | 1,174 | 1,185 | 1,172 | 1,175 | -11 | -0.9% | 4,214,100 |
2011/09/08 | 1,190 | 1,196 | 1,181 | 1,186 | +4 | +0.3% | 1,437,700 |
2011/09/07 | 1,183 | 1,188 | 1,172 | 1,182 | +9 | +0.8% | 1,394,300 |
2011/09/06 | 1,190 | 1,199 | 1,173 | 1,173 | -17 | -1.4% | 1,595,100 |
2011/09/05 | 1,201 | 1,205 | 1,186 | 1,190 | -18 | -1.5% | 1,546,100 |
2011/09/02 | 1,208 | 1,216 | 1,202 | 1,208 | -9 | -0.7% | 1,609,200 |
2011/09/01 | 1,230 | 1,241 | 1,214 | 1,217 | -12 | -1% | 1,344,200 |
2011/08/31 | 1,220 | 1,230 | 1,215 | 1,229 | +15 | +1.2% | 1,484,500 |
2011/08/30 | 1,233 | 1,234 | 1,214 | 1,214 | -10 | -0.8% | 1,925,200 |
2011/08/29 | 1,224 | 1,230 | 1,214 | 1,224 | +1 | +0.1% | 867,800 |
2011/08/26 | 1,220 | 1,229 | 1,216 | 1,223 | +4 | +0.3% | 983,500 |
2011/08/25 | 1,241 | 1,247 | 1,217 | 1,219 | -9 | -0.7% | 983,300 |
2011/08/24 | 1,263 | 1,265 | 1,224 | 1,228 | -31 | -2.5% | 1,415,600 |
3301~
3350
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 235,100円 | +5.7% | +3.9% | 2.61% | 11.69倍 | 1.55倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 741,400円 | +2.2% | +10.2% | 1.62% | 14.24倍 | 1.44倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 143,100円 | +0.9% | +380.2% | 5.45% | 19.71倍 | 1.69倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 406,600円 | +1.7% | -2.9% | 3.94% | 26.68倍 | 1.40倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 209,100円 | -3.5% | -11.3% | 2.87% | 19.20倍 | 1.29倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム